{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:57:58Z","timestamp":1790657878950,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["2021C03100"],"award-info":[{"award-number":["2021C03100"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.heliyon.2023.e23933","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T21:48:53Z","timestamp":1703022533000},"page":"e23933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ovarian response determines the luteinizing hormone suppression threshold for patients following the gonadotrophin releasing hormone antagonist protocol: A retrospective cohort study"],"prefix":"10.1016","volume":"10","author":[{"given":"Qingfang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingru","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyue","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9667-3677","authenticated-orcid":false,"given":"Yimin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.heliyon.2023.e23933_bib1","first-page":"209","article-title":"Luteinizing hormone changes in gonadotropin-releasing hormone antagonist protocol in in vitro fertilization cycles: a cross-sectional study","volume":"17","author":"Hosein Rashidi","year":"2019","journal-title":"Int. J. Reprod. Biomed."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23933_bib2","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.fertnstert.2007.10.058","article-title":"Does day 3 luteinizing-hormone level predict IVF success in patients undergoing controlled ovarian stimulation with GnRH analogues?","volume":"90","author":"Orvieto","year":"2008","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23933_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.fertnstert.2005.09.067","article-title":"Optimal stimulation protocols for in vitro fertilization","volume":"86","author":"Muasher","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.heliyon.2023.e23933_bib4","article-title":"The serum follicle stimulating hormone-to-luteinizing hormone ratios can predict assisted reproductive technology outcomes in women undergoing gonadotropin releasing hormone antagonist protocol","volume":"14","author":"Zhao","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23933_bib5","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1038\/s41598-022-08400-z","article-title":"Conventional GnRH antagonist protocols versus long GnRH agonist protocol in IVF\/ICSI cycles of polycystic ovary syndrome women: a systematic review and meta-analysis","volume":"12","author":"Kadoura","year":"2022","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23933_bib6","doi-asserted-by":"crossref","first-page":"258","DOI":"10.25122\/jml-2021-0286","article-title":"Effect of early GnRH antagonist administration on assisted reproductive technique outcomes in normal responders","volume":"15","author":"Al-Obaidi","year":"2022","journal-title":"J. Med. Life"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23933_bib7","first-page":"556","article-title":"Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols","volume":"32","author":"Toftager","year":"2017","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23933_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/humrep\/dev342","article-title":"Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization","volume":"31","author":"Lindgren","year":"2016","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.heliyon.2023.e23933_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1477-7827-11-51","article-title":"A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology","volume":"11","author":"Alviggi","year":"2013","journal-title":"Reprod. Biol. Endocrinol."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23933_bib10","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0015-0282(02)03157-6","article-title":"The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation","volume":"77","author":"Shoham","year":"2002","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.heliyon.2023.e23933_bib11","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0015-0282(97)81407-0","article-title":"Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation","volume":"67","author":"Albano","year":"1997","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23933_bib12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.fertnstert.2005.08.048","article-title":"Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol","volume":"85","author":"Griesinger","year":"2006","journal-title":"Fertil. Steril."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23933_bib13","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1093\/humrep\/17.8.2016","article-title":"Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation","volume":"17","author":"Humaidan","year":"2002","journal-title":"Hum. Reprod."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23933_bib14","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/humrep\/del219","article-title":"A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF\/ICSI cycles leads to lower live birth rates","volume":"21","author":"Lahoud","year":"2006","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23933_bib15","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1210\/en.2018-00123","article-title":"Luteinizing hormone Facilitates antral follicular maturation and survival via thecal paracrine signaling in cattle","volume":"159","author":"Hattori","year":"2018","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23933_bib16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.fertnstert.2011.06.042","article-title":"Is a premature rise in luteinizing hormone in the absence of increased progesterone levels detrimental to pregnancy outcome in GnRH antagonist in vitro fertilization cycles","volume":"96","author":"Dovey","year":"2011","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23933_bib17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1080\/09513590.2019.1683730","article-title":"The effect of a transient premature luteinizing hormone surge without elevated serum progesterone on in vitro fertilization outcomes in a gonadotropin-releasing hormone antagonist flexible protocol","volume":"36","author":"Zhang","year":"2020","journal-title":"Gynecol. Endocrinol."},{"issue":"10","key":"10.1016\/j.heliyon.2023.e23933_bib18","first-page":"137","article-title":"Comparison of different stimulation protocols used in in vitro fertilization: a review","volume":"3","author":"Shrestha","year":"2015","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23933_bib19","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.fertnstert.2017.09.020","volume":"109","author":"Toftager","year":"2018","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23933_bib20","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.fertnstert.2018.03.031","article-title":"Multicenter evaluation of the Access AMH antim\u00fcllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation","volume":"110","author":"Baker","year":"2018","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23933_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/humupd\/dmp036","article-title":"Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART)","volume":"16","author":"La Marca","year":"2010","journal-title":"Hum. Reprod. Update"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23933_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.fertnstert.2010.04.006","article-title":"Correlation of ovarian reserve tests with histologically determined primordial follicle number","volume":"95","author":"Hansen","year":"2011","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23933_bib23","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.fertnstert.2015.01.004","article-title":"Prospective study into the value of the automated Elecsys antim\u00fcllerian hormone assay for the assessment of the ovarian growing follicle pool","volume":"103","author":"Anderson","year":"2015","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23933_bib24","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.fertnstert.2012.12.048","article-title":"Antim\u00fcllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients","volume":"99","author":"Arce","year":"2013","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23933_bib25","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.fertnstert.2014.12.114","article-title":"Comparison of antim\u00fcllerian hormone levels and antral follicle count as predictor of ovarian response to controlled ovarian stimulation in good-prognosis patients at individual fertility clinics in two multicenter trials","volume":"103","author":"Nelson","year":"2015","journal-title":"Fertil. Steril."},{"issue":"7","key":"10.1016\/j.heliyon.2023.e23933_bib26","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria","volume":"26","author":"Ferraretti","year":"2011","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.heliyon.2023.e23933_bib27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3389\/fendo.2019.00281","article-title":"Ovarian reserve markers to identify poor responders in the context of poseidon classification","volume":"10","author":"Grisendi","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23933_bib28","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/humrep\/deu266","article-title":"Ovarian response prediction in GnRH antagonist treatment for IVF using anti-M\u00fcllerian hormone","volume":"30","author":"Hamdine","year":"2015","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23933_bib29","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.fertnstert.2009.10.047","article-title":"Racial and ethnic differences in reproductive potential across the life cycle","volume":"93","author":"Butts","year":"2010","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.heliyon.2023.e23933_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1030201","article-title":"Analysis of relative factors and prediction model for optimal ovarian response with gonadotropin-releasing hormone antagonist protocol","volume":"13","author":"Jiang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.heliyon.2023.e23933_bib31","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3389\/fendo.2019.00639","article-title":"Low LH level on the day of GnRH agonist trigger is associated with reduced ongoing pregnancy and live birth rates and increased early miscarriage rates following IVF\/ICSI treatment and fresh embryo transfer","volume":"10","author":"Benmachiche","year":"2019","journal-title":"Front. Endocrinol."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23933_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humrep\/deh601","article-title":"Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF\/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy","volume":"20","author":"Huirne","year":"2005","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23933_bib33","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S0015-0282(02)04920-8","article-title":"Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy","volume":"79","author":"Kolibianakis","year":"2003","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.heliyon.2023.e23933_bib34","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/humrep\/dep436","article-title":"Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)","volume":"25","author":"Lainas","year":"2010","journal-title":"Hum. Reprod."},{"issue":"6","key":"10.1016\/j.heliyon.2023.e23933_bib35","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/humrep\/der037","article-title":"The Istanbul consensus workshop on embryo assessment: proceedings of an expert meeting","volume":"26","year":"2011","journal-title":"Hum. Reprod."},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23933_bib36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.rbmo.2020.03.023","article-title":"The performance of the Elecsys\u00ae anti-M\u00fcllerian hormone assay in predicting extremes of ovarian response to corifollitropin alfa","volume":"41","author":"Neves","year":"2020","journal-title":"Reprod. Biomed. Online"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23933_bib37","first-page":"370","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"31","author":"Drakopoulos","year":"2016","journal-title":"Hum. Reprod."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23933_bib38","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1093\/humrep\/deu090","article-title":"Prognostic models for high and low ovarian responses in controlled ovarian stimulation using a GnRH antagonist protocol","volume":"29","author":"Broekmans","year":"2014","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23933_bib39","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/humrep\/des389","article-title":"High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol","volume":"28","author":"Fatemi","year":"2013","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23933_bib40","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.fertnstert.2021.01.056","article-title":"Validation study of the Access antim\u00fcllerian hormone assay for the prediction of poor ovarian response to controlled ovarian stimulation","volume":"116","author":"Baker","year":"2021","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.heliyon.2023.e23933_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.612042","article-title":"Oligo\/amenorrhea is an independent risk factor associated with low ovarian response","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"1","key":"10.1016\/j.heliyon.2023.e23933_bib42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/cen.12886","article-title":"The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: a prospective randomized controlled study","volume":"84","author":"Younis","year":"2016","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23933_bib43","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","volume":"4","author":"Al-Inany","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.heliyon.2023.e23933_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fendo.2019.00067","article-title":"LH levels may Be used as an indicator for the time of antagonist administration in GnRH antagonist protocols-A proof-of-concept study","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.heliyon.2023.e23933_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.640047","article-title":"Low serum LH levels during ovarian stimulation with GnRH antagonist protocol decrease the live birth rate after fresh embryo transfers but have No impact in freeze-all cycles","volume":"12","author":"Luo","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.heliyon.2023.e23933_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005070.pub2","article-title":"Recombinant Luteinizing Hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles","volume":"2","author":"Mochtar","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"issue":"16","key":"10.1016\/j.heliyon.2023.e23933_bib47","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11164670","article-title":"Does serum LH level influence IVF outcomes in women with PCOS undergoing GnRH-antagonist stimulation: a novel indicator","volume":"11","author":"Wang","year":"2022","journal-title":"J. Clin. Med."},{"issue":"8","key":"10.1016\/j.heliyon.2023.e23933_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047974","article-title":"Luteinising hormone-based protocol versus traditional flexible gonadotropin-releasing hormone antagonist protocol in women with normal ovarian response: study protocol for a non-inferiority trial","volume":"11","author":"Lv","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/j.heliyon.2023.e23933_bib49","article-title":"Luteinizing hormone-based modified GnRH antagonist protocol in normal responders undergoing in vitro fertilization treatment: a multi-center randomized controlled trial","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.heliyon.2023.e23933_bib50","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.fertnstert.2019.12.007","article-title":"Frozen-thawed embryo transfer: the potential importance of the corpus luteum in preventing obstetrical complications","volume":"113","author":"Singh","year":"2020","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.heliyon.2023.e23933_bib51","article-title":"An endometrial receptivity scoring system basing on the endometrial thickness, volume, echo, peristalsis, and blood flow evaluated by ultrasonography","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.heliyon.2023.e23933_bib52","first-page":"1","article-title":"Evaluation of endometrial receptivity by ultrasound elastography to predict pregnancy outcome is a non-invasive and worthwhile method","author":"Li","year":"2023","journal-title":"Biotechnol. Genet. Eng. Rev."},{"issue":"4","key":"10.1016\/j.heliyon.2023.e23933_bib53","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/uog.21969","article-title":"Uterine artery Doppler in singleton pregnancies conceived after in-vitro fertilization or intracytoplasmic sperm injection with fresh vs frozen blastocyst transfer: longitudinal cohort study","volume":"56","author":"Cavoretto","year":"2020","journal-title":"Ultrasound Obstet. Gynecol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023111418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844023111418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:21:20Z","timestamp":1790655680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844023111418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2405844023111418"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23933","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ovarian response determines the luteinizing hormone suppression threshold for patients following the gonadotrophin releasing hormone antagonist protocol: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2023.e23933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e23933"}}